Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United States.
作者信息
Ratevosian Jirair, Piselli Caroline, Sullivan Patrick, Nelson LaRon E
机构信息
Yale School of Nursing, Yale University, New Haven, Connecticut, USA.
Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.
出版信息
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26504. doi: 10.1002/jia2.26504.
Abstract
摘要
相似文献
1
Leveraging existing market incentives to increase HIV pre-exposure prophylaxis access in the United States.利用现有市场激励措施增加美国的艾滋病病毒暴露前预防药物可及性。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26504. doi: 10.1002/jia2.26504.
2
The Effects of MyChoices and LYNX Mobile Apps on HIV Testing and Pre-Exposure Prophylaxis Use by Young US Sexual Minority Men: Results From a National Randomized Controlled Trial.MyChoices和LYNX移动应用程序对美国年轻性少数男性进行艾滋病毒检测及使用暴露前预防措施的影响：一项全国随机对照试验的结果
JMIR Public Health Surveill. 2025 Feb 5;11:e63428. doi: 10.2196/63428.
3
Does pre-exposure prophylaxis for HIV prevention in men who have sex with men change risk behaviour? A systematic review.男男性行为者的 HIV 预防暴露前预防是否会改变风险行为？系统评价。
J Clin Nurs. 2018 Sep;27(17-18):3254-3265. doi: 10.1111/jocn.13990.
4
Investigating the potential accessibility to HIV pre-exposure prophylaxis via community pharmacies and sexual health clinics: a scoping review of two integrated care systems in London.通过社区药房和性健康诊所调查获得艾滋病毒暴露前预防药物的潜在可及性：对伦敦两个综合医疗系统的范围审查
BMC Health Serv Res. 2025 Jul 1;25(1):878. doi: 10.1186/s12913-025-12985-2.
5
Implementing the new WHO guidelines on HIV post-exposure prophylaxis: perspectives from five African countries.实施世界卫生组织关于艾滋病病毒暴露后预防的新指南：来自五个非洲国家的观点。
J Int AIDS Soc. 2025 Jun;28 Suppl 1:e26447. doi: 10.1002/jia2.26447.
6
Navigating Barriers and Opportunities: Perceptions of the Non-Occupational Post-Exposure Prophylaxis Care Continuum Among Young Sexual Minority Men, Aged 17-24, in the United States.导航障碍与机遇：17-24 岁美国年轻性少数男性对非职业暴露后预防护理连续性的认知。
AIDS Patient Care STDS. 2024 Jun;38(6):267-274. doi: 10.1089/apc.2024.0012. Epub 2024 Jun 12.
7
Untapped potential of post-exposure prophylaxis in sub-Saharan Africa: a comparative analysis of PEP implementation planning in Kenya, Mozambique, Nigeria, Uganda and Zambia.撒哈拉以南非洲地区暴露后预防的未开发潜力：肯尼亚、莫桑比克、尼日利亚、乌干达和赞比亚暴露后预防实施规划的比较分析。
J Int AIDS Soc. 2025 Jun;28 Suppl 1:e26471. doi: 10.1002/jia2.26471.
8
A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care.美国急诊部门实施 HIV 暴露前预防 (PrEP) 的系统评价：患者筛查、处方和与护理的衔接。
J Community Health. 2024 Jun;49(3):499-513. doi: 10.1007/s10900-023-01320-7. Epub 2023 Dec 21.
9
Online delivery of oral HIV pre- and post-exposure prophylaxis: findings from the ePrEP Kenya pilot.口服艾滋病毒暴露前和暴露后预防药物的在线配送：肯尼亚电子预防试点项目的结果
J Int AIDS Soc. 2025 Jun;28 Suppl 1(Suppl 1):e26468. doi: 10.1002/jia2.26468.
10
Barriers and facilitators to HIV Pre-Exposure Prophylaxis (PrEP) in Specialist Sexual Health Services in the United Kingdom: A systematic review using the PrEP Care Continuum.英国性健康专科服务中 HIV 暴露前预防（PrEP）的障碍和促进因素：使用 PrEP 护理连续模型的系统评价。
HIV Med. 2023 Aug;24(8):893-913. doi: 10.1111/hiv.13492. Epub 2023 Apr 19.
引用本文的文献
1
Expanding access to a choice-based multi-method PrEP market for HIV prevention.扩大获得基于选择的多种方法的预防艾滋病病毒暴露前预防（PrEP）市场的机会。
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26512. doi: 10.1002/jia2.26512.
本文引用的文献
1
Factors Associated With PrEP Utilization and Access in the United States.美国与暴露前预防（PrEP）使用及可及性相关的因素
AIDS Educ Prev. 2024 Dec;36(6):446-452. doi: 10.1521/aeap.2024.36.6.446.
2
Preexposure Prophylaxis (PrEP) for HIV.艾滋病毒暴露前预防（PrEP）
JAMA. 2024 Nov 12;332(18):1574-1575. doi: 10.1001/jama.2024.16984.
3
Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: a population-based analysis.在美国暴露前预防（PrEP）的首个十年中，按种族、族裔、性别和地区划分的PrEP使用公平性：一项基于人群的分析。
Lancet Reg Health Am. 2024 Apr 22;33:100738. doi: 10.1016/j.lana.2024.100738. eCollection 2024 May.
4
Geographic Variation in Qualified Health Plan Coverage and Prior Authorization Requirements for HIV Preexposure Prophylaxis.HIV 暴露前预防的合格健康计划覆盖范围和事先授权要求的地域差异。
JAMA Netw Open. 2023 Nov 1;6(11):e2342781. doi: 10.1001/jamanetworkopen.2023.42781.
5
Estimated Lifetime HIV-Related Medical Costs in the United States.美国预计终身艾滋病毒相关医疗费用。
Sex Transm Dis. 2021 Apr 1;48(4):299-304. doi: 10.1097/OLQ.0000000000001366.
6
Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.政策和县级层面与 HIV 暴露前预防用药的使用相关因素分析，美国，2018 年。
Ann Epidemiol. 2020 May;45:24-31.e3. doi: 10.1016/j.annepidem.2020.03.013. Epub 2020 Apr 3.
7
HIV Preexposure Prophylaxis: A Review.HIV 暴露前预防：综述。
JAMA. 2018 Mar 27;319(12):1261-1268. doi: 10.1001/jama.2018.1917.
Zotero 插件